Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP993090priorityCriticalpatent/ECSP993090A/en
Publication of ECSP993090ApublicationCriticalpatent/ECSP993090A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Composición farmacéutica de administración oral que contiene un inhibidor de lipasas gastrointestinales, uno (o más) compuesto (s) adicional (es) del grupo consistente en quitosán, sus derivados y sales de los mismos, y exipientes auxiliares.Orally administered pharmaceutical composition containing a gastrointestinal lipase inhibitor, one (or more) additional compound (s) from the group consisting of chitosan, its derivatives and salts thereof, and auxiliary excipients.
ECSP9930901999-08-051999-08-05
PHARMACEUTICAL COMPOSITION OF ERIZO PROTEINS AND THEIR USE
ECSP993090A
(en)
HETEROAROMATIC COMPOUNDS REPLACED AS INHIBIDORESS TIROSIN QUINASA, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THE PREPARATION OF MEDICINES
Cyclooxygenase inhibitor and amidine derivative salts, process for their preparation, use thereof as drugs, and pharmaceutical compositions containing such derivatives
Combination therapy for HIV infection using the HIV protease inhibitor indinavir and the reverse transcriptase inhibitor 3TC, possibly in combination with AZT, DDI, or DDC